Translate this page into:
Quality of life of family caregivers of children with psoriasis

*Corresponding author: Nora Mohamed Abdelrazik, Department of Dermatology, Venerology, and STDs, Faculty of Medicine, Mansoura University, Mansoura, Egypt. noraeldarawany@gmail.com
-
Received: ,
Accepted: ,
How to cite this article: Abdelrazik NM, Selim MK, El-Gilany AH, Wagdy A, Elkholy AM. Quality of life of family caregivers of children with psoriasis. J Compr Dermatol. 2025;1:4. doi: 10.25259/JCD_11_2024
Abstract
Objectives:
Psoriasis (PsO) is a chronic skin disease, with one-third of cases occurring during childhood. The impact of PsO is not limited to the child but also inevitably extends to the caregiver. The current study aimed to measure quality of life (QoL) of caregivers of children with PsO and its associated factors.
Material and Methods:
A cross-sectional descriptive study with an analytic component included 165 caregivers of children diagnosed with various types of PsO for at least 6 month’s duration. The severity of PsO was assessed with the Psoriasis Area and Severity Index (PASI) score, and caregivers’ QoL was assessed using the family dermatology life quality index (FDLQI). Mann-Whitney and Kruskal-Wallis tests were used to compare non-normally distributed data. Linear regression was applied to evaluate the contribution of factors found to be significantly correlated with the square root of QoL. Qualitative variables were included in the model as dummy variables. A p-value of ≤0.05 was regarded as statistically significant.
Results:
Both median and mean QoL scores among studied caregivers were 11 out of 30 (36.7% of total score). Median QoL scores were higher among caregivers with very low and low socioeconomic levels (p < 0.001), caregivers of preschool children (p = 0.04), children with previous hospitalization for PsO, pustular PsO, face, scalp, and genital involvement (p = 0.01, 0.003, 0.02, 0.03, and < 0.001, respectively). Moderate to severe PsO had a higher median QoL score compared to mild PsO (p < 0.001). Linear regression revealed that the independent predictors of impaired QoL among caregivers were socioeconomic status, genital involvement, and severity of PsO.
Conclusion:
Caregivers of children with PsO experienced a relatively impaired QoL. Many caregiver- and patient-related factors were associated with a low QoL score among caregivers.
Keywords
Caregiver
Childhood psoriasis
FDLQI
PASI score
Quality of life (QoL)
INTRODUCTION
Psoriasis (PsO) is a primarily immune-mediated disease with a genetic and environmental background, where activation of keratinocytes and immune cells causes hyperproliferation of keratinocytes.1 It is a clinically heterogeneous, lifelong skin disease that manifests in multiple forms, including plaques, flexural, guttate, pustules, and erythroderma.2
PsO affects approximately 2% of the population worldwide, and nearly one-third of patients develop PsO within the first 20 years of life.3 The disease can present at any age, typically between the ages of 9 and 10 years.4 The history and symptoms vary depending on the child’s age and the type of PsO.5 PsO in infants usually manifests as well-demarcated erythematous plaques in the diaper area, including the inguinal and perianal areas.6
Quality of life (QoL) is a multifaceted concept encompassing physical and psychological well-being, social relationships, and socioeconomic factors.7 Pediatric PsO (age of onset <18 years) has a significant negative impact on QoL, and patients are at higher risk of developing psychosocial disorders compared to patients without PsO.8 Additionally, pediatric patients with PsO suffer from social discomfort, bullying, and stigma due to the visibility of psoriatic plaques.9,10
Chronic skin diseases have been shown to impact not only the QoL of patients but also the QoL of their families, who share the overall burden of the disease.11–13 This important aspect of the QoL model was conceptualized as “The Greater Patient,” introduced by Basra and Finlay in 200714 to describe the immediate close social group affected by a person having skin disease.
Considering the chronic course of the disease, the frequent use of inconvenient treatments in pediatric patients, and the emotional and financial dependence of children on their caregivers, childhood PsO can pose a significant burden to parents and other family members.15
Clinical evaluation of children with PsO usually requires assessing and monitoring the QoL of parents and caregivers, taking into account the possibility of psychological support.16 The family dermatology life quality index (FDLQI), designed by Basra et al., is a validated dermatology-specific instrument designed to assess and quantify the impact on the QoL of family members of patients with skin diseases during the preceding month.17,18
Improving family QoL can help reduce family psychological distress and help build a supportive relationship with parents, which in turn can lead to improved patient compliance and outcomes.16
Rationale and objectives
Although several studies have assessed the QoL of children with PsO, few studies have measured the impact of PsO on the QoL of families. Understanding the impact of childhood PsO on families is important for developing treatment and support strategies.
The current study aimed to measure the QoL of caregivers of children with PsO using the FDLQI questionnaire and its associated clinical and demographic characteristics.
MATERIALS AND METHODS
Ethical approval
This study was approved by the Institutional Review Board (IRB) of Mansoura Faculty of Medicine (MD.21.05.474). Informed consent was taken before the inclusion of caregivers into the study. All necessary precautions were taken to ensure data privacy. All data were used for scientific purposes only.
Study design and participants
A cross-sectional descriptive study with an analytic component was conducted from August 2021 to March 2023. A total of 165 caregivers and their psoriatic children were consecutively recruited while attending the Dermatology outpatient clinic of Mansoura University Hospital, Egypt. The sample size was calculated, using Medcalc 15.8 (https://www.medcalc.org/), based upon mean FDLQI = 13.62 and SD = 6.15 in a previous study by Żychowska et al.19 With an alpha error of 5%, a study power of 80%, and 10% precision, the sample size was 162 child-caregiver dyads. However, we recruited 165 child-caregiver dyads. Cooperative caregivers of infants from 9 months of age up to 12-year-old children with at least a 6-month history of PsO and different treatment regimens were included. Children in this age range are largely dependent on caregivers for nutrition, medical care, and daily activities. In contrast, older children tend to exhibit greater independence in managing their basic needs. Children and family caregivers with mental illness or with chronic systemic or dermatological conditions other than PsO were excluded from the study.
A questionnaire was constructed to collect the following
Children Data
Detailed history: Personal history (e.g., name, age, sex, and education); family history and parental consanguinity; present history (onset, course, duration of disease, precipitating factors, and current treatment regimen); and past history (treatment history and previous hospitalization for PsO).
Detailed general examination: Assessment of mental awareness and exclusion of any other chronic systemic disease.
Dermatologic examination: The diagnosis of PsO was mainly based on clinical, dermoscopic, and/or histopathological examination. Once PsO was diagnosed, it was classified into PsO vulgaris, erythrodermic, pustular, and arthropathic PsO. Involvement of special sites, including the face, scalp, hand, nail, genital area, and joints, was recorded. The Psoriasis Area and Severity Index (PASI) score was used to assess the severity of PsO, and a score of ≥10 was considered moderate to severe PsO.20
Caregivers’ Data
Sociodemographic characteristics were measured using the validated socioeconomic scale of El-Gilany et al.21 The final scale included 7 domains with a total score of 84 divided into four levels.
Care-related characteristics: Relation to the patient; main caregiver and living with the patient or not; duration of caregiving; and number of healthcare visits in the last 6 months.
Assessment of QoL: Using the Arabic version of FDLQI licensed by Cardiff University (License ID CUQoL3187). The questionnaire consists of 10 questions assessing various aspects of life. Each question requires one response from four separate options: not at all/not relevant, a little, quite a lot, and very much, with scores of 0, 1, 2, and 3, respectively.19 The total score is calculated by summing the score of each question, resulting in a maximum of 30 and a minimum of 0. The higher the score, the more the QoL is impaired, and vice versa.
Data collection
Patients and their family caregivers were enrolled in the study consecutively until the desired sample size was achieved. Face-to-face interviews were conducted with the patient and their caregiver for data collection purposes.
Statistical analysis and data interpretation
IBM SPSS Statistics for Windows, Version 25.0 (IBM Corp., 2017), was used for statistical analysis. Median (minimum-maximum) was used to express non-normally distributed continuous data. Categorical data were shown as number and percentage. Mann-Whitney and Kruskal-Wallis tests were used to compare non-normally distributed data. Since the QoL score and its log did not follow a normal distribution, its square root was calculated to normalize it for use in linear regression. Linear regression was applied to evaluate the contribution of factors found to be significantly correlated with the square root of QoL. Qualitative variables were included in the model as dummy variables. A p-value of ≤0.05 was regarded as statistically significant.
RESULTS
Sociodemographic characteristics of psoriatic children and their effect on caregivers’ QoL
The median overall QoL score among studied caregivers was 11 (36.7% of the total score). QoL was significantly impaired in caregivers of preschool children compared to those in primary and preparatory education (p = 0.04) [Table 1].
| Variable | Total N (%) | QoL score Median (min-max) | p-value |
|---|---|---|---|
| Overall | 165 | 11 (0–27)a | - |
| Age (years) (mean ± SD) | 8.4 ± 3 | ||
| <6 | 44 (26.7) | 10.5 (0–23) | 0.8 |
| 6–12 | 121 (73.3) | 11 (0–27) | |
| Sex | |||
| Male | 75 (45.5) | 10 (5–14) | 0.2 |
| Female | 90 (54.5) | 11 (7–15.25) | |
| Education | |||
| Preschool | 38 (23) | 14 (3–27)b,c | 0.04 |
| Primary | 99 (60) | 10 (0–25)b | |
| Preparatory | 28 (17) | 11.5 (0–24)c | |
| Family history | |||
| Negative | 119 (72.1) | 11 (0–27) | 0.4 |
| Positive | 46 (27.9) | 9.5 (0–25) | |
| Parental consanguinity | |||
| Negative | 123 (74.5) | 10 (0–27) | 0.3 |
| Positive | 42 (25.5) | 12 (2–25) | |
Clinical characteristics of psoriatic children and their effect on caregivers’ QoL
There were statistically significantly higher median QoL scores in caregivers of children with previous hospitalization for PsO and children with a history of a combination treatment regimen (p = 0.01 and 0.03, respectively). The most common PsO subtype was PsO vulgaris (99.4%), followed by pustular PsO (3.6%). The most common involved special site was the scalp (60.6%), followed by the nail (43.6%) [Table 2].
| Variable | Total N (%) | QoL score Median (min-max) | p-value |
|---|---|---|---|
| Skin type | |||
| II and III | 52 (31.5) | 11 (3–25) | 0.6 |
| IV and V | 113 (68.5) | 10 (0–27) | |
| Duration of disease (median (IQR) | 12 (6–36) | ||
| ≤12 months | 88 (53.3) | 10 (0–25) | 0.9 |
| >12 months | 77 (46.7) | 11 (0–27) | |
| Previous hospitalization for psoriasis | |||
| No | 150 (90.9) | 10 (0–25) | 0.01 |
| Yes | 15 (9.1) | 14 (5–27) | |
| Treatment history | |||
| Topical | 118 (71.5) | 10 (0–25) | 0.03 |
| Combination | 47 (28.5) | 12 (4–27) | |
| Precipitating factors: | |||
| Obesity | |||
| No | 161 (97.6) | 11 (0–27) | 0.4 |
| Yes | 4 (2.4) | 8 (5–14) | |
| Streptococcal infection | |||
| No | 138 (83.6) | 10 (0–27) | 0.3 |
| Yes | 27 (16.4) | 12 (1–24) | |
| Stress | |||
| No | 151 (91.5) | 10 (0–27) | 0.4 |
| Yes | 14 (8.5) | 12.5 (4–21) | |
| Systemic drugs | |||
| No | 162 (98.2) | 11 (0–25) | 0.9 |
| Yes | 3 (1.8) | 10 (4–27) | |
| Psoriasis subtypea: | |||
| Psoriasis vulgaris | |||
| No | 1 (0.6) | 7 | 0.5 |
| Yes | 164 (99.4) | 11 (0–27) | |
| Pustular psoriasis | |||
| No | 159 (96.4) | 10 (0–25) | 0.003 |
| Yes | 6 (3.6) | 16 (14–27) | |
| Erythrodermic psoriasis | |||
| No | 163 (98.8) | 11 (0–27) | 0.8 |
| Yes | 2 (1.2) | 10 (7–13) | |
| Psoriatic arthritis | |||
| No | 164 (99.4) | 10.5 (0–27) | 0.06 |
| Yes | 1 (0.6) | 24 | |
| Special sites of involvement: | |||
| Face involvement | |||
| No | 112 (67.9) | 10 (0–25) | 0.02 |
| Yes | 53 (32.1) | 12 (0–27) | |
| Scalp involvement | |||
| No | 65 (39.4) | 8 (0–24) | 0.03 |
| Yes | 100 (60.6) | 11 (0–27) | |
| Nail involvement | |||
| No | 93 (56.4) | 11 (0–27) | 0.3 |
| Yes | 72 (43.6) | 10 (0–25) | |
| Genital involvement | |||
| No | 118 (71.5) | 9.5 (0–24) | <0.001 |
| Yes | 47 (28.5) | 14 (4–27) | |
| Hand involvement | |||
| No | 120 (72.7) | 10 (0–24) | 0.06 |
| Yes | 45 (27.3) | 12 (0–27) | |
| Total PASI | |||
| Mild | 116 (70.3) | 9.5 (0–24) | <0.001 |
| Moderate or sever | 49 (29.7) | 13 (2–27) | |
| Current treatment | |||
| Topical | 138 (83.6) | 10 (0–27)b | 0.02 |
| Phototherapy | 1 (0.6) | 12 | |
| Systemic/biologic | 3 (1.8) | 15 (7–18) | |
| Combination | 23 (13.9) | 13 (5–25)b |
Caregivers of children with pustular PsO have statistically significantly higher median QoL scores compared to patients without pustular PsO (p = 0.003). Median QoL scores were statistically significantly higher in the caregivers of children with face, scalp, and genital involvement (p = 0.02, 0.03, and < 0.001, respectively). Moderate to severe PsO as measured with the PASI score had statistically significantly higher median QoL scores compared to mild PsO (p < 0.001). The current combination treatment regimen had statistically significant higher median QoL scores compared to topical treatment (p = 0.02) [Table 2].
QoL according to caregivers’ clinical and care-related characteristics
Caregivers with very low/low socioeconomic status had statistically significantly higher median QoL scores compared to those with middle/high socioeconomic status (p < 0.001) [Table 3].
| Variable | Total N (%) | QoL score Median (min-max) | p-value |
|---|---|---|---|
| Age (mean ± SD) | 34.3 ± 7.3 | ||
| <30 | 51 (30.9) | 11 (1–25) | 0.7 |
| ≥30 | 114 (69.1) | 10.5 (0–27) | |
| Sex | |||
| Male | 7 (4.2) | 11 (4–17) | 0.9 |
| Female | 158 (95.8) | 10.5 (0–27) | |
| Current marital status | |||
| Married | 155 (93.9) | 11 (0–27) | 0.5 |
| Not marrieda | 10 (6.1) | 10.5 (8–24) | |
| Education | |||
| <High school | 44 (26.7) | 14 (0–27) | 0.1 |
| High school | 87 (52.7) | 10 (0–25) | |
| >High school | 34 (20.6) | 8.5 (0–24) | |
| Occupation | |||
| Housewife | 111 (67.3) | 10 (0–27) | 0.08 |
| Manual worker | 34 (20.6) | 13.5 (0–25) | |
| Semiprofessional/professional | 20 (12.1) | 9.5 (0–18) | |
| Residence | |||
| Rural | 123 (74.5) | 10 (0–25) | 0.9 |
| Urban slum/Urban | 42 (25.5) | 11 (0–27) | |
| Socioeconomic level | |||
| Very low/low | 87 (52.7) | 12 (0–27) | <0.001 |
| Middle/high | 78 (47.3) | 8 (0–25) | |
| Relationship with the patient | |||
| Mother | 150 (90.9) | 10.5 (0–27) | 0.6 |
| Othersb | 15 (9.1) | 11 (4–27) | |
| Main caregiver | |||
| Yes | 160 (97) | 11 (0–27) | 0.2 |
| No | 5 (3) | 7 (4–17) | |
| Living with patient | |||
| Yes | 162 (98.2) | 11 (0–27) | 0.6 |
| No | 3 (1.8) | 7 (4–17) | |
| Number of healthcare visits in last 6 months | |||
| ≤2 | 99 (60) | 11 (0–27) | 0.6 |
| >2 | 66 (40) | 10 (0–25) | |
| Number of children | |||
| ≤2 | 46 (27.9) | 10 (2–25) | 0.8 |
| >2 | 119 (72.1) | 11 (0–27) | |
Correlation of QoL with significant variables and independent predictors of QoL among studied caregivers
There was a weak but significant negative correlation between QoL square root and caregivers’ education, socioeconomic scale, and child education. However, there was a positive correlation between the square root of the QoL score and current treatment, treatment history, previous hospitalization, presence of pustular PsO, involvement of the face, scalp, and genital areas, and PASI score [Table 4a, Figure 1].
| Variable | QoL square root | |
|---|---|---|
| r | p-value | |
| Caregiver education | −0.2 | 0.003 |
| Socioeconomic scale | −0.3 | ≤0.001 |
| Child education | −0.2 | 0.03 |
| Current treatment | 0.2 | 0.003 |
| Treatment history | 0.2 | 0.03 |
| Previous hospitalization | 0.2 | 0.01 |
| Pustular psoriasis | 0.2 | 0.003 |
| Face involvement | 0.2 | 0.02 |
| Scalp involvement | 0.2 | 0.03 |
| Genital involvement | 0.4 | <0.001 |
| PASI | 0.3 | <0.001 |
Qualitative variables were entered into the model as dummy variables, with caregiver education coded as 0 < high school, 1 high school, and 2 > high school. Child education: 0: preschool, 1: primary, 2: preparatory; treatment history coded as 0: topical, 1: combination. For current treatment, 0: topical, 1: phototherapy, 2: systemic, 3: combination. In addition, 0 was given for no previous hospitalization, no pustular psoriasis, no face involvement, no scalp involvement, and no genital involvement.

- Correlation between PASI score and QoL square root.
Multivariate linear regression analysis revealed that independent predictors of QoL among caregivers of psoriatic children were genital involvement, socioeconomic status, and severity of PsO (p ≤ 0.001, ≤ 0.001, and 0.013, respectively) [Table 4b].
| Variables | B | p-value |
|---|---|---|
| Genital involvement | 0.6 | ≤ 0.001 |
| Socioeconomic score | −0.04 | ≤ 0.001 |
| PASI score | 0.014 | 0.013 |
| Constant | 4.46 | |
| Model F | 19.3 | |
| Model R2 | 0.52 | |
| p-value | ≤0.001 | |
The qualitative variable (genital involvement) was entered into the model as a dummy variable (0 = no and 1 = yes). p value of ≤ 0.05 was regarded as statistically significant.
DISCUSSION
Family caregivers play a crucial role in the well-being of individuals suffering from chronic diseases. The quality of care provided by the caregiver is often related to their own physical and psychological health. The FDLQI was used in the current study to evaluate the effect of childhood PsO on caregivers’ QoL and revealed a relatively impaired QoL among caregivers. Our results agreed with many previous studies that reported impaired QoL of caregivers of children with PsO.12,19,22–25
Gånemo et al.12 used the dermatitis family impact questionnaire and assessed the QoL of caregivers of Swedish infants and children with PsO and found that it was impaired, especially with earlier onset of PsO. In the Turkish population, two studies assessed the QoL of caregivers of psoriatic children. The first is the Salman et al.24 study, FDLQI was used to assess caregivers’ QoL. QoL of the caregivers was relatively impaired, showing a slightly better outcome (median FDLQI of 10) than that reported in the current study. The slightly lower score in their study could be attributed to a smaller sample size with relatively mild disease severity of the subjects. The second study done by Tekin et al.25 measured the QoL of caregivers of 129 children with PsO using the validated Turkish version of the Dermatology Family Impact Scale and showed that childhood PsO had a significant impact on the QoL of caregivers.
In Poland, Zychowska et al.19 reported that pediatric PsO had a significant impact on caregivers’ QoL with a median QoL score of 12.0. The slightly higher median FDLQI score despite a smaller sample size (only 65 caregivers) may be due to the inclusion of caregivers with chronic diseases, including PsO (6%), causing a more impaired QoL. However, caregivers with any chronic disease that affects the QoL were excluded from our study. According to Kim et al.22 Australian study, families’ QoL was significantly reduced when a child has PsO (median FDLQI of 12 points). Our results agreed with Elgamal et al.,23 who demonstrated that childhood PsO had a significant impact on the QoL of the caregivers in Egypt with a mean FDLQI of 13 ± 5.1.
In the current study, most caregivers were females, with mothers comprising the predominant group. Our results followed Salman et al.,24 Tekin et al.,25 and Zychowska et al.,19 with mothers representing 84.5%, 82.9%, and 93.85%, respectively. The strongly established model of role division in the family, with the father typically being the main earner and the mother spending more time caring for the children, is the possible explanation of these results. Żychowska et al.15 examined the differential impact of childhood PsO on maternal and paternal well-being using the Polish version of the FDLQI and found that mothers’ QoL was significantly more impaired than fathers’. Although a previous Ukraine study carried out by Chernyshov26 found no significant gender difference among parents in the evaluation of the impact of dermatitis on the families of children with atopic dermatitis, both studies agreed that the difference, if present, may be due to the diversity of ways of thinking and habits within the couple, rather than to gender itself. However, we cannot rely on our results regarding this impact difference, as the majority who completed the questionnaire were mothers versus only seven fathers. There was no statistically significant association between caregivers’ ages and their QoL in the current study, and this agreed with previous studies by Zychowska et al.19 and Żychowska et al.15
An individual’s well-being depends on demographic, social, and psychological factors, as well as a stable income to support oneself and one’s family. In our analysis, caregivers with low socioeconomic status had significantly higher QoL scores, indicating greater impairment, with a significant negative correlation between socioeconomic level and QoL. These results are consistent with an Indian study by Nayak et al.27 who investigated the correlation between financial status and QoL in PsO. They found a significant negative correlation between patients’ family income and the Dermatology Life Quality Index (DLQI). The costs of treatment, transportation to the hospital, and the need to leave frequently from work to take care of the child can all affect the caregiver both physically and psychologically.
We didn’t find any significant differences between boys and girls in the impact of PsO on their parents’ QoL. This agrees with many previous studies.12,15,22,23 Controversial results in Tekin et al.25 Turkish study demonstrating greater QoL impairment in caregivers of boys than girls. On the other hand, Zychowska et al.19 found that caregivers of girls had higher FDLQI scores than caregivers of boys in Poland but did not reach statistical significance. Cultural differences might affect the outcomes of childcare-related studies and explain these controversial results.
Median QoL scores were significantly higher in preschool children compared to those with primary and preparatory education. Less educated children depend more on their caregivers and are less able to participate in their care routine, resulting in a greater impairment of QoL in their families, explaining the significant negative correlation between the child’s education and QoL score.
The presence of previous hospitalization for PsO was associated with a more impaired caregivers’ QoL with a significant positive correlation. Along with ignoring their obligations at home and work, parents should stay with their ill child, causing disruptions to their daily routine, raising some anxieties, and increasing their stress and frustration levels. The same explanation would apply to pustular PsO, which is associated with an increased risk of hospitalization and the presence of frequent systemic manifestations such as fever and malaise, which make it a risk factor for impaired QoL, with a significant positive correlation. Our results are in line with Elgamal et al.,23 who demonstrated that pustular PsO had the maximum mean FDLQI scores and then a more impaired QoL.
Involvement of the face, scalp, and genital areas was associated with statistically significant higher median QoL scores in our analysis. Our findings followed previous studies by Tekin et al.25 and Elgamal et al.,23 who reported that scalp involvement was associated with a statistically significant higher Children’s Dermatology Life Quality Index (CDLQI) and FDLQI, respectively. Scalp involvement, along with its possible effects (e.g., dandruff on clothes, difficulty combing hair, and visibility of the lesions, may have a significant impact on the psychosocial well-being of children and their caregivers, explaining the previous findings. Facial lesions are highly visible and can impair vision and hearing; as a result, they can significantly impair the QoL of both children and caregivers. Itching, soreness, irritation, and the caregiver’s worry about the child’s sexual health in the future are the possible causes of such marked impairment of QoL in genital PsO.28
In our analysis, caregivers of children with moderate or severe PsO had statistically significant higher median QoL scores compared to caregivers of children with mild PsO, which is consistent with many previous studies.12,23–25 A previous study in Australia by Kim et al.22 was conducted to investigate the relationship between FDLQI and PASI and reported a significant positive correlation between the two variables. Given that patients with more severe PsO have a variety of issues that affect many aspects of daily life. Increased symptom severity, including itching, scaling, and involvement of larger body surface area, can be the possible explanation for this significant correlation.29 However, Zychowska et al.19 and Żychowska et al.15 found that the FDLQI of the caregivers was not correlated with the severity of PsO measured by PASI.
Caregivers of children with both a history of combination treatment and current combination treatment had significantly higher median QoL scores than those receiving topical treatment only, with a significant positive correlation. Our results followed Tekin et al.,25 who emphasized that caregivers of patients receiving systemic medications or phototherapy were found to be impaired in several aspects of QoL. Some of these were treatment-related, such as the financial burden of treatment and the time spent caring for patients.
To investigate the independent predictors associated with FDLQI, multivariate linear regression analysis was done. It revealed that genital involvement, socioeconomic status, and severity of PsO were significantly associated with FDLQI. On the other hand, the independent predictors of dermatological family impact scale in a previous study by Tekin et al.25 were treatment status, CDLQI, and arthritis.
Recommendations
Caregivers of children with genital involvement, severe PsO, and those with very low or low socioeconomic status can benefit from counseling and social support.
To reduce the caregiver burden, simplifying treatment plans can enhance adherence and ease daily responsibilities. Telemedicine should be utilized to reduce travel and time demands. Additionally, schools should be engaged to support daily care routines, and families should have access to financial assistance programs to reduce economic strain.
Study limitations
The cross-sectional design does not allow for exploring the temporality cause-effect relation. The findings are applicable only to parents of patients attending the hospital and may not necessarily reflect the situation in the community. Being a single-center study with a relatively small sample size affects the external validity (generalizability) of the data.
CONCLUSION
This study supports the concept of the “Greater Patient” as the psychosocial effect of pediatric PsO extends beyond the patient. Caregivers of children with PsO experience a relatively impaired QoL. The independent predictors of impaired QoL among caregivers include socioeconomic status, genital involvement, and severity of PsO.
Author contributions:
NMA: Writing – original draft, Data curation (case collection), Methodology (questionnaire construction). AME: Conceptualization, Supervision, Writing – review and editing (major revisions). A-H E-G: Formal analysis (statistical analyses and sample-size calculation), Methodology (statistical), Writing – review and editing. MKS: Writing – review and editing, Intellectual input. AW: Writing – review and editing, Intellectual input.
Ethical approval:
The research/study was approved by the Institutional Review Board at the Institutional Review Board (IRB) of Mansoura Faculty of Medicine, number MD.21.05.474, dated 12th June 2021.
Declaration of patient consent:
The authors certify that they have obtained all appropriate patient consent.
Conflicts of interest:
There are no conflicts of interest.
Use of artificial intelligence (AI)-assisted technology for manuscript preparation:
The authors confirm that there was no use of artificial intelligence (AI)-assisted technology for assisting in the writing or editing of the manuscript and no images were manipulated using AI.
Financial support and sponsorship: Nil.
References
- Focus: Skin: Current developments in the immunology of psoriasis. Yale J Biol Med. 2020;93:97-110.
- [Google Scholar]
- Pediatric psoriasis: From new insights into pathogenesis to updates on treatment. Biomedicines. 2021;9:940.
- [CrossRef] [PubMed] [Google Scholar]
- Clinical profile of childhood-onset psoriasis and prevalence of HLACw6: A hospital-based study from India. Postgrad Med J. 2015;91:309-14.
- [CrossRef] [PubMed] [Google Scholar]
- Perianal lesions in children: An updated review. Am J Clin Dermatol. 2017;18:343-54.
- [CrossRef] [PubMed] [Google Scholar]
- Study protocol for the World Health Organization project to develop a Quality of Life assessment instrument (WHOQOL) Qual Life Res. 1993;2:153-9.
- [CrossRef] [Google Scholar]
- Pediatric patients with psoriasis and psychiatric disorders: Premorbidity and comorbidity in a case-control study. J Dermatolog Treat. 2019;30:129-34.
- [CrossRef] [PubMed] [Google Scholar]
- Internalized stigma in pediatric psoriasis: A comparative multicenter study. Ann Dermatol. 2020;32:181-8.
- [CrossRef] [PubMed] [Google Scholar]
- Quality of life in children with psoriasis: Results from a monocentric study. Ital J Dermatol Venerol. 2021;156:374-7.
- [CrossRef] [PubMed] [Google Scholar]
- Quality of life in persons living with psoriasis patients. J Am Acad Dermatol. 2014;71:302-7.
- [CrossRef] [PubMed] [Google Scholar]
- Quality of life and clinical features in Swedish children with psoriasis. Pediatr Dermatol. 2011;28:375-9.
- [CrossRef] [PubMed] [Google Scholar]
- Psoriasis: Is it the tip of the iceberg for the quality of life of patients and their families? J Eur Acad Dermatol Venereol. 2011;25:1282-7.
- [CrossRef] [PubMed] [Google Scholar]
- The family impact of skin diseases: The Greater Patient concept. Br J Dermatol. 2007;156:929-37.
- [CrossRef] [PubMed] [Google Scholar]
- Comparison of the impact of childhood psoriasis on mothers' and fathers' quality of life-does gender of a caregiver play a role? J Eur Acad Dermatol Venereol. 2021;35:685-92.
- [CrossRef] [PubMed] [Google Scholar]
- Quality of life In: Pediatric psoriasis (1st ed). Switzerland: Springer; 2022. p. :111-4.
- [CrossRef] [Google Scholar]
- The family dermatology life quality index: Measuring the secondary impact of skin disease. Br J Dermatol. 2007;156:528-38.
- [CrossRef] [PubMed] [Google Scholar]
- Measurement of family impact of skin disease: Further validation of the Family Dermatology Life Quality Index (FDLQI) J Eur Acad Dermatol Venereol. 2008;22:813-21.
- [CrossRef] [PubMed] [Google Scholar]
- Impact of childhood psoriasis on caregivers' quality of life, measured with family dermatology life quality index. Acta Derm Venereol. 2020;100:1-12.
- [CrossRef] [PubMed] [Google Scholar]
- Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures. J Am Acad Dermatol. 2021;84:432-70.
- [CrossRef] [PubMed] [Google Scholar]
- Updating and validation of the socioeconomic status scale for health research in Egypt. East Mediterr Health J. 2012;18:962-8.
- [CrossRef] [PubMed] [Google Scholar]
- Relationship between PASI and FDLQI in paediatric psoriasis, and treatments used in daily clinical practice. Australas J Dermatol. 2021;62:190-4.
- [CrossRef] [PubMed] [Google Scholar]
- Quality of life in mothers of children with psoriasis. J Cosmet Dermatol. 2023;22:2560-4.
- [CrossRef] [PubMed] [Google Scholar]
- Impact of psoriasis in the quality of life of children, adolescents and their families: A cross-sectional study. An Bras Dermatol. 2018;93:819-23.
- [CrossRef] [PubMed] [Google Scholar]
- Assessment of quality of life in Turkish children with psoriasis and their caregivers. Pediatr Dermatol. 2018;35:651-9.
- [CrossRef] [PubMed] [Google Scholar]
- May the gender of a parent influence assessment of health-related quality of life, family impact and severity of atopic dermatitis in children? Pediatr Dermatol. 2009;26:99-100.
- [CrossRef] [PubMed] [Google Scholar]
- Correlation between disease severity, family income, and quality of life in psoriasis: A study from South India. Indian Dermatol Online J. 2018;9:165-9.
- [CrossRef] [PubMed] [Google Scholar]
- Underdiagnosed and undertreated psoriasis: Nuances of treating psoriasis affecting the scalp, face, intertriginous areas, genitals, hands, feet, and nails. Dermatol Ther. 2018;31:e12589.
- [CrossRef] [PubMed] [Google Scholar]
- Relationship between psoriasis severity, clinical symptoms, quality of life and work productivity among patients in the USA. Clin Exp Dermatol. 2016;41:514-21.
- [CrossRef] [PubMed] [Google Scholar]

